Position in ALNY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$3,136,646
-$1,051,799 QoQ
Shares Held
9,480
-10.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.13080168776371.ToString("F0")%
Shared 2.848101265822785.ToString("F0")%
None 0.02109704641350211.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COMMERCE BANK holds $27,782,414 across 24 Biotechnology names. ALNY ranks #4 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,448 | $4,981,982 | |
| 2 | EXEL |
Exelixis, Inc.
|
88,824 | $3,809,659 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,535 | $3,364,678 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
9,480 | $3,136,646 | |
| 5 | MRNA |
Moderna, Inc.
|
48,508 | $2,464,206 | |
| 6 | INCY |
Incyte Corp
|
19,518 | $1,837,033 | |
| 7 | TECH |
BIO-TECHNE Corp
|
34,131 | $1,783,685 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
17,860 | $1,154,291 |
All Filings in ALNY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,136,646 | 9,480 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,188,445 | 10,533 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,066,136 | 4,531 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,479,143 | 4,536 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $1,230,480 | 4,557 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $1,059,364 | 4,502 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,243,684 | 4,522 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,121,931 | 4,617 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $695,838 | 4,656 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $896,372 | 4,683 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $815,722 | 4,606 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $869,544 | 4,578 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $923,074 | 4,608 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,057,542 | 4,450 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $896,116 | 4,477 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $3,594,764 | 24,647 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $711,617 | 4,358 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $722,071 | 4,258 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $799,987 | 4,237 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $990,166 | 5,841 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $817,207 | 5,788 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $5,144,992 | 39,586 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $5,028,295 | 34,535 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $4,631,102 | 31,268 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $487,647 | 4,480 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||